International Variations in AAA Screening

Introduction Abdominal aortic aneurysm (AAA) screening programmes reduce AAA-related mortality and are cost-effective. This study aims to assess the state and variability of AAA screening programmes worldwide. Methods Data were obtained from an international expert group convened at the 34th Charing...

Full description

Saved in:
Bibliographic Details
Published in:European journal of vascular and endovascular surgery 2013-03, Vol.45 (3), p.231-234
Main Authors: Stather, P.W, Dattani, N, Bown, M.J, Earnshaw, J.J, Lees, T.A
Format: Article
Language:English
Subjects:
Adult
Aged
Aneurysm
Aortic Aneurysm, Abdominal - diagnosis
Aortic Aneurysm, Abdominal - economics
Aortic Aneurysm, Abdominal - mortality
Aortic Aneurysm, Abdominal - surgery
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - economics
Cost-Benefit Analysis - economics
Endovascular
EVAR
Female
Humans
Male
Mass Screening - economics
Mass Screening - methods
Middle Aged
Risk Factors
Screening
Surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Abdominal aortic aneurysm (AAA) screening programmes reduce AAA-related mortality and are cost-effective. This study aims to assess the state and variability of AAA screening programmes worldwide. Methods Data were obtained from an international expert group convened at the 34th Charing Cross Symposium as well as government websites and published reports on screening programmes. Results Six countries are in the process of implementing national AAA screening programmes, with Italy still performing screening trials. There is wide variability in inclusion criteria between countries with the majority screening only men in their 65th year, however 3 programmes include women, 2 programmes only include patients with high cardiovascular risk, and 2 trials are also screening for hypertension and lower limb atherosclerosis. Surveillance intervals vary between screening programmes, with the most common regimen being to vary the surveillance interval depending upon aneurysm size, however the optimum surveillance interval in terms of decreasing mortality and cost effectiveness remains uncertain. Discussion International dissemination of current AAA screening programme outcomes is required to inform developing programmes about optimum screening intervals, benefits of surveillance of the subaneurysmal aorta, and screening for other cardiovascular disease.
ISSN:1078-5884
1532-2165
DOI:10.1016/j.ejvs.2012.12.013